ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1429.0529900327056;7.697632086000634;0.04782911751220199;0.8417775754447168;[PRKAR1B, PRKAR2B, PKIG, SIRT1]
GO:2000481;positive regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1426.5997261217476;8.16763571524637;0.0477470089768964;0.8658135829017477;[ADRB2, SIRT1]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CSF3, NCF1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, IL18, SIRT1, PTK2, DCN, FGR, SELP, GH1, NEDD4, KIT, CD28, PTPN6, TEK]
GO:0090335;regulation of brown fat cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;28.146757669690793;7.069023426578259;9.420466487672394E-4;0.6846304993685643;[DUSP10, PRDM16, PTGS2, MAPK14, SIRT1]
GO:0031081;nuclear pore distribution;7.0;1.0;0.8509193652572005;9.628524252492122;71.75212521717813;8.67846133901236;0.0024014790582986725;0.7947362817240173;[NUP133]
GO:0090611;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;7.0;1.0;0.8509193652572005;9.628524252492122;51.84712944745551;8.16763571524637;0.001735276763219217;0.7686126355688037;[VPS4B]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62, CDK1]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[RAD54B, RAD50, RAD51, RAD51C, RAD21]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[EDN1, PIK3CD, GATA3, PIK3C2A, PIK3R5, AKT1]
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[NFKBIA, IL10, G3BP2, CCDC22]
GO:1904179;positive regulation of adipose tissue development;6.0;1.0;0.8231203125901445;9.628524252492122;84.15966440839325;8.16763571524637;0.0028167482289683326;0.7408135829017477;[NR1H4, SIRT1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;663.4179201744114;5.8650506222523235;0.02220400075087234;0.6961795867550195;[GAB1, PIK3CD, PIK3R3, PIK3C2A, FGF5, PIKFYVE]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[CDKN1A, BRCA2, SIRT1, PML, PYCARD, MSH2, BCL3]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CEP120, CXCR4, CDH1, PRDM16, EPHB1, TGFB2, ANXA1, NUP133, BCL11B, BCL11A, CIT, FABP7]
GO:0008585;female gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;6.8867018697843045;0.001705743211299806;0.6424272657460779;[NUP107, BRCA2]
GO:0061738;late endosomal microautophagy;5.0;1.0;0.7902410118609202;9.628524252492122;39.83166466328102;8.67846133901236;0.0013331299701091492;0.7340579283277371;[VPS4B]
GO:0000973;posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery;6.0;1.0;0.8231203125901445;9.628524252492122;21.24116723228514;8.67846133901236;7.10922751455178E-4;0.7669372290569613;[NUP107]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, HMOX1, PTGS2, PIK3C2A]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[BLM, PCNA, BRCA2, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, ISG15, SIRT1, POLA1, POLE2, RPA3, DTL]
GO:0000972;transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.24116723228514;7.697632086000634;7.10922751455178E-4;0.6838982747154925;[NUP107, NUP133, NUP155]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0060766;negative regulation of androgen receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;234.23542340630428;7.292166977892469;0.007839648823214116;0.747921758369865;[DAB2, SIRT1]
GO:0001542;ovulation from ovarian follicle;4.0;1.0;0.75;9.628524252492122;27.16069640012757;7.697632086000634;9.090440654724862E-4;0.6436572628545723;[ADAMTS1, MMP19, SIRT1]
GO:0010934;macrophage cytokine production;5.0;1.0;0.7902410118609202;9.628524252492122;22.637273805675832;9.083926447120524;7.576491820522217E-4;0.7547934328124444;[SIRT1]
GO:0018394;peptidyl-lysine acetylation;9.0;0.6696747006330769;0.7310779754968275;8.884083777544626;313.638027190515;5.076593261888053;0.010497182514167671;0.6558578406789737;[SPI1, BRCA2, RUVBL2, RUVBL1, ACTL6A, SIRT1, POR, TAF9, LEF1, ELP4, NAT8, TAF5]
GO:0000183;chromatin silencing at rDNA;12.0;1.0;0.9481203125901445;9.628524252492122;1754.5970941496832;7.292166977892469;0.058724785706324785;0.8210420709600095;[SUV39H1, SIRT1]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, SPP1, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:0010259;multicellular organism aging;4.0;0.9326813400603323;0.7163406700301662;9.474373572664863;29.177677042081047;6.943860283624253;9.765505923939418E-4;0.6051093378270707;[EDN1, NDUFS6, SEC63]
GO:0034983;peptidyl-lysine deacetylation;9.0;1.0;0.896240625180289;9.628524252492122;328.6076320466096;7.8311634786251565;0.010998201716931447;0.7967266896635242;[SIRT1]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, SIRT1]
GO:0032288;myelin assembly;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;32.851297377660025;7.292166977892469;0.0010995033589821146;0.6631627702307852;[PIKFYVE, PMP22, TLR2]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[FCN1, TNF, PYCARD, CLEC5A, SOX4, WLS, POSTN, PRKCE, F2R, GOLPH3L, MIF, ADAM9, ADAM8, CLEC4E, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, TMEM27, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, CRTAM, IL6, ACHE, ORM1, LRRK2, PTPN22, ARRB1, IFIH1, CD38, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, DDX58, RIPK2, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, EXOC1, NOD2, CD58, CCL19, IL33, NR1H2, NR1H4, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0030301;cholesterol transport;7.0;0.7763722522362496;0.7391054913753253;8.999915593069748;37.84975072563126;5.845247994956144;0.0012667970942227542;0.6498456195510879;[ABCA1, MSR1, CAV1, VPS4B, CLU, CD36, CFTR, ABCG2]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, PLK1, RANBP6, PML, COL1A1, PIKFYVE, NUP35, RAN]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, LCP2, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR, PIKFYVE]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[ADRB2, SESN3, HMOX1, RIPK2, TSC2, SIRT1, DCN]
GO:0034063;stress granule assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.069023426578259;0.0035913979925534566;0.7124295520356204;[EIF2S1, G3BP2]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[CD74, TWIST1, SNAI2, MIF, SIRT1]
GO:0046628;positive regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;293.6040497598144;7.069023426578259;0.009826663318971241;0.7124295520356204;[NR1H4, SIRT1, PRKCZ, GNAI2]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[CD74, TAF9, MIF, SIRT1]
GO:0051261;protein depolymerization;6.0;0.7192862368539868;0.682763431017138;8.712233520617966;39.9935520007603;6.250713103064308;0.001338548193605436;0.6427820713687392;[VPS4B, VIL1, KIF18A, STMN1, KIF2C]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, PDGFA, PIK3C2A, PDGFRL, NR4A3, PDGFD, PDGFC]
GO:0044321;response to leptin;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;25.223505691001428;6.943860283624253;8.44208035796484E-4;0.6453503496879909;[CCNA2, EDN1, PID1, NR4A3, SIRT1]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, COL1A2, BCL6, LAT, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, PDPN, EPS8L1, EPS8L3]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[EVI5, EHD3, PIKFYVE]
GO:1904903;ESCRT III complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;38.04764185170599;7.474488534686424;0.0012734203321220245;0.7053660038532718;[VPS4B]
GO:0019076;viral release from host cell;7.0;0.8436909121759173;0.7727648213451592;9.387362195675234;33.814119637874356;7.9853141584524145;0.001131728153547711;0.7592887026755414;[VPS4B]
GO:0001678;cellular glucose homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;49.180086311476984;5.514393750639154;0.0016460132296410052;0.6329257181104212;[FOXO1, HK3, LGALS1, SOX4, MEN1, SIRT1, PAX2, NME1, LIN28A, IL1B, NOX4, FOXA3]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, PIK3CD, GATA3, PIK3C2A, PIK3R5, AKT1, KCNH1, PDGFRB, PDGFRA, EDN1, GSN, GAB2, EXOC1]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0051097;negative regulation of helicase activity;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;49.94359093049245;8.390779266560578;0.0016715670421299067;0.7522251544931926;[IFIT1, SIRT1, MCM2]
GO:0010825;positive regulation of centrosome duplication;10.0;0.8933024483968273;0.861892236059334;9.582004236857228;269.74818055260414;7.9853141584524145;0.009028228845494321;0.8236103492792612;[VPS4B, NUP62, CEP120]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[SESN3, AKT1, TSC2, RRAGD, ADRB2, HMOX1, LRRK2, RIPK2, SIRT1, DCN, RAB33B, EXOC1, PIKFYVE, NEDD4]
GO:0034976;response to endoplasmic reticulum stress;4.0;0.6799073451904818;0.5899536725952409;8.284789505791027;28.997869804256865;4.300610075748959;9.705326059599744E-4;0.4699333992726228;[TRIM25, TMX1, TLN1, ATF3, JUN, WFS1, TNFRSF10B, EIF2AK2, EIF2S1, BCL2, SRPX, FKBP14, PPP1R15A, CEBPB, FAM129A, THBS1, CCL2, PML, PSMC6, PSMC2]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, ARRB2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:1903542;negative regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;247.76337772234075;8.67846133901236;0.008292417279803399;0.8400575416471059;[VPS4B]
GO:1903543;positive regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;273.97956964224545;7.069023426578259;0.009169849630321672;0.757750811958709;[VPS4B, IFNG, HGS, SDC1]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PIK3C2A, AKT1, GAB1, PIK3R3, PRKCZ, FOXO1, CAV2, SORBS1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CD34, RPA1, SIRT1, RPA3]
GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.600353375525426;999.3623287810346;6.781341354126479;0.033447757776597226;0.7620391240755716;[SOD2, SIRT1, VNN1, AKT1]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, ABCB4, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, PLCG2, HMOX1, SFN, NCKAP1L, BARD1, FZD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, GPR37, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, GPNMB, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF3, TNF, CLU, CTGF, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, PSAP, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, LRP1, VPS4B, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, DNAJA3, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, SOX4, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, CD34, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CST3, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;4.406435599552807;0.001508456149618737;0.5762646867385423;[IL1RN, GOLT1B, ZFAND6, RORA, TNF, PYCARD, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, TNFAIP3, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, RHOH, ZDHHC17, SIRT1, IL1B, TLR6, ZMYND11, BIRC2, LTF, BIRC3, NLRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, NR1H4, CD4, NLRP12, LTBR]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, RORA, NLRC3, PYCARD, NR1H4, RHOH, SIRT1, NLRP12, CCDC22, ZMYND11]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, RARA, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, CEBPD, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[DCLRE1A, FEN1, BRCA1, BRCA2, H2AFX, ESCO2, PARP9, RAD51C, MSH2, BLM, PSMD14, CDCA5, RAD54B, RAD21, RBBP8, RAD54L, BARD1, GINS2, RPA1, MLH1, POLA1, RAD50, RAD51, RPA3]
GO:0006813;potassium ion transport;7.0;0.7980440201809971;0.7499413753476991;9.310070521373587;34.16983994150393;4.61801832846594;0.001143633791982704;0.587085037334763;[KCNK5, KCNG2, AQP1, KCNH1, KCNH2, KCND2, ATP1B2, ATP1B1, KCNQ1, SLC24A2, SLC24A4, KCNE3, KCNE4, VPS4B, SLC1A3, KCNA5, KCNMB3, KCNN3, SLC12A2, SLC12A1, KCNJ15, KCNJ16, FXYD2]
GO:0048268;clathrin coat assembly;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;44.51706700895919;6.781341354126479;0.0014899461700306506;0.6699184248047958;[PIK3C2A, CLINT1]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[ABCA1, NFKBIA, LRP1, NR1H2, SIRT1]
GO:2000774;positive regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.05173707047635;7.474488534686424;0.005490664002770884;0.7331650565203278;[HMGA1, PAWR, SIRT1]
GO:0016197;endosomal transport;5.0;0.7090535922965819;0.6447678080092112;8.817594036275793;47.18803257139101;4.463867648638682;0.0015793409836922997;0.5185234110033771;[ZFYVE16, HGS, EVI5, ABCA1, EHD3, DENND1B, ARL4C, VPS4B, SORT1, PIKFYVE, SNX17]
GO:2000655;negative regulation of cellular response to testosterone stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;79.37071810283105;9.777073627680469;0.0026564665058930264;0.7902410118609202;[SIRT1]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[PLEKHF1, HGS, VPS4B]
GO:0051028;mRNA transport;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;42.48893056556077;4.77312732173501;0.0014220662684744023;0.6190979532066485;[NUP107, FMR1, MAGOH, SLBP, NUP205, SEH1L, NUP160, NUP85, G3BP2, NUP88, NUP155, UPF3B, AHCTF1, HHEX, XPO1, NUP62, NUP133, NUP54, NUP43, RANBP2, MX2, NUP35, NUPL2, NUP37]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[BCL6, PLK2, TWIST1, SLC30A10, SIRT1]
GO:1902188;positive regulation of viral release from host cell;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;120.05257821018927;7.069023426578259;0.004018051752389216;0.7365101867784198;[CAV2, VPS4B, SMC3]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[DGAT2, POLD1, NR1H4, SIRT1]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[CDKN1A, PLEKHF1, EHMT2, LRRK2, KRT20, SESN3, LAMP2, UPP1, SIRT1, RRAGD, SIK1, ATF3, SEH1L, FOXO1, GAS2L1, JUN, EIF2AK2, EIF2S1, BCL2, FOXA3]
GO:0000720;pyrimidine dimer repair by nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;368.1807062307652;8.67846133901236;0.012322676896420592;0.8400575416471059;[SIRT1]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, CD40, PTGS2, PIK3C2A, THBS1, ETS1, AKT1, HMOX1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[ACHE, TAGLN, TWIST1, AEBP1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0010923;negative regulation of phosphatase activity;9.0;0.7866048967936545;0.7895430735771163;9.362821086759116;265.75489588375854;5.142344639450834;0.008894577201350937;0.659220369185286;[PLEKHF1, TNF, PPP1R12A, PPP1R15A, PKMYT1, GNAI2, NCKAP1L, TGFB2, FKBP1B]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, TNFSF11, TRIM25, TLE4, PCOLCE, SIRT1, PADI2, KLF4, PML, BSPRY, KLF5]
GO:0051152;positive regulation of smooth muscle cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;145.28799013580416;7.292166977892469;0.004862658279143298;0.7238411236270654;[MYOCD, TGFB1, SMARCD3, KIT, SOD2, SIRT1, ENG]
GO:2000785;regulation of autophagosome assembly;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;101.62596648496498;6.166155715036245;0.0034013296408198605;0.6903374900225189;[LRRK2, RAB33B, PIKFYVE]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, AKT1, HMOX1, PLCG1, IL10, PPP1R16B, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0031204;posttranslational protein targeting to membrane, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;169.63248762716802;8.67846133901236;0.005677446701553932;0.8590579283277371;[SEC63]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, VPS4B, CDCA8, CCNB1, NUP62, CENPE, KIF18A, PSRC1, KIF2C]
GO:0070857;regulation of bile acid biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;200.7778490682047;7.474488534686424;0.0067198539199799295;0.7572456912631272;[NR1H4, SIRT1]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[TGFB1I1, HTRA1, PRDM16, EMILIN1, TGFB1, CAV2, CAV1, SIRT1, DNM2, TGFBR3, FBN1]
GO:0021915;neural tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;6.409777797693995;0.0011047978665365144;0.618037346520142;[STIL, TGFB1, NUP133, TCF7, GRHL2]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, PIK3C2A, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, ARRB2, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, PRKCZ, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:1902237;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;829.3805359816347;7.292166977892469;0.027758620145282933;0.7881627702307852;[SIRT1, ATF3]
GO:0045841;negative regulation of mitotic metaphase/anaphase transition;11.0;0.8436909121759173;0.8542744084176208;9.5544162803384;1557.3872016210385;6.7325511899570465;0.052124348080771515;0.7767319332797141;[PLK1, BUB1B, CENPF, RAD21, BUB1, MAD1L1, MAD2L1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0051292;nuclear pore complex assembly;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;123.37008173774021;7.474488534686424;0.004129085609897011;0.7053660038532718;[NUP205, AHCTF1, NUP107]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[FBL, SUV39H1, SIRT1, NOP56]
GO:0045724;positive regulation of cilium assembly;9.0;0.8933024483968273;0.8428918493787028;9.537552474286395;366.9725033529874;6.7325511899570465;0.012282239433413365;0.740543606130341;[CEP120]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, SERPING1, CFD, FPR1, PDGFA, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, EXOC1, SERPINB10, GRN, PTAFR, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, PIK3CD, ITGAL, PIK3C2A, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, CCL8, TTR, CCL5, PCDH7, CPPED1, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, A2M, CCR1, PRG2, NBEAL2, PPBP, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSW, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, STX11, CST3, PAK1, CXCR1, CXCR2, CD58, CCT8, GCA, LHFPL2, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, APLP2, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MYH10, MGAM, TGFB2, TGFB1, SYT2, HSPA6, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, TNFAIP2, CXCL1, SIRPB1, HK3, PLAUR, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:1903724;positive regulation of centriole elongation;12.0;1.0;0.9481203125901445;9.628524252492122;583.3918737387858;9.777073627680469;0.01952560099543789;0.9481203125901445;[VPS4B]
GO:0006642;triglyceride mobilization;8.0;1.0;0.875;9.628524252492122;86.98015092181912;8.390779266560578;0.0029111473742996327;0.8041048419030481;[SIRT1]
GO:0050872;white fat cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.292166977892469;7.282666309192915E-4;0.6631627702307852;[CEBPA, PRDM16, SIRT1]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[RORA, HNF1B, SIRT1, PML, PPP1CA, MC3R, LGR4]
GO:0006999;nuclear pore organization;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;38.430292282043744;7.069023426578259;0.0012862272976623997;0.6517511986393402;[NUP205, AHCTF1, SEH1L, NUP107, NUP133, NUP35, NUP54]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[LEF1, FSTL1, TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, BMP2, ZFYVE16, ID1, ENG]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, E2F1, HMOX1, FABP1, BCL2]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[FMR1, SIRPG, SERPINE1, TNF, CLU, PYCARD, LGALS3, SIRPA, CD177, SLC11A1, TSC2, ACTN4, SFRP4, ZFYVE16, PRTN3, EPHA3, CD151, C2, C3, PLCG2, STAP1, NCKAP1L, CD14, TGFB1, CAV1, AZU1, SELE, TF, DAB2, MCTP1, LRRK2, ARRB1, ARRB2, SIRPB1, CD36, FCER1G, SYK, DNM2, FGR, GREM1, HCK, IL1B, TLR2, NLGN1, LRP1, DLL1, RAB21, NTF3, CCL2, CSK, CCL19, SNCA, CCL21, EGF, NR1H2, LILRB1, SNX17, PTX3, FCGR2B]
GO:0032007;negative regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;5.926926025970411;0.008015432820232688;0.6781032725983739;[SESN3, TSC2, SIRT1, SIK1]
GO:0035356;cellular triglyceride homeostasis;8.0;1.0;0.875;9.628524252492122;50.566380672597894;7.8311634786251565;0.001692411254323797;0.7754860644832351;[DGAT2, NR1H4, SIRT1]
GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.212124270218933;0.0014007232725606145;0.6919486831672181;[TWIST1, SIRT1]
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle;9.0;0.811012628672052;0.801746939516315;9.394909401310617;357.14964968422294;5.926926025970411;0.011953477361114177;0.699343897778663;[BLM, BRCA1, AURKB, RAD21, TOPBP1, NAE1, FANCI, DONSON, CDC6, MSH6, CDK1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, CEBPA, CSF3, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:0051601;exocyst localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;7.57984905034425;0.001364603831334836;0.710754145523778;[, TNFAIP2, EXOC1]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, H2AFX, PARP9, SIRT1]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[CDCA5, PLK1, BUB1B, ESCO2, SMC1A, SMC3, PHB2, CDC20, RAD51C, STAG2, PPP2R1A, RAD21, BUB1]
GO:0070914;UV-damage excision repair;8.0;1.0;0.875;9.628524252492122;251.03601357316452;7.292166977892469;0.008401949456549422;0.747921758369865;[SIRT1]
GO:0033210;leptin-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;30.19135422731818;7.57984905034425;0.00101047745553359;0.738553198190834;[SIRT1]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[GFI1, TNFAIP3, ARRB1, ARRB2, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, G3BP2, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[VPS4B, PLK1, SMC1A, SMC3, STAG2]
GO:0031393;negative regulation of prostaglandin biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;814.0923329901884;9.083926447120524;0.02724693774964864;0.8797934328124444;[SIRT1]
GO:0061647;histone H3-K9 modification;8.0;0.8436909121759173;0.7968454560879586;9.488762310116963;187.05115224840347;7.138016298065211;0.0062604337306462815;0.7400384854347593;[EHMT2, SUV39H1, ARID4A, ARID4B, SIRT1]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[GOLPH3L, DNM2, RAB31, GOPC, CCDC22, EXOC1]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[TXNDC15, SLC11A1, TMX1]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SPARC, TFRC, CLEC10A, ICAM3, KIAA1109, DPYSL2, CUBN, SLC11A1, HSPG2, RIN2, CFI, FPR2, CD14, IGHA1, ELANE, SLAMF1, MSR1, MARCO, DENND1B, ACHE, ADM, CLINT1, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, NME1, CEACAM1, RARA, RHOU, CD302, CD5L, TMPRSS2, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SNX17, NEDD4, SIGLEC1, RAMP1, SCARB2, NCF2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, CD93, TSC2, RAB31, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, DAB2, IGKV3-20, LRP12, BCL2L1, LRRK2, ITGB3, ITGB2, ARRB1, ARRB2, ITGAL, PIK3C2A, GHR, ITGA4, DNM2, PECAM1, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1A, FCGR1B, ATP9A, SNCA, NLGN4Y, CD6, CD5, CD9, FCGR2B]
GO:0046822;regulation of nucleocytoplasmic transport;6.0;0.6547035408479693;0.6504720830141292;8.529911963824013;30.746838917960506;5.040875179285974;0.0010290690282256237;0.5809109036834981;[CDKN1A, LRRK2, XPO1, CDH1, NUP62, CD36, MED1, PPP1R12A, PRKCD, SIRT1, IFNG, MDFIC, IFI27, IL1B, NUP54, SP100, PTGS2, SFN, ECT2, BARD1, TGFB1, JUP, MX2, MAPK14, NEDD4, CDK1, CAMK1, PKIG]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[NUP107, HHEX, NUP62, MAGOH, NUP133, NUP54, SLBP, NUP205, SEH1L, NUP160, NUP85, NUP43, NUP88, RANBP2, NUP155, UPF3B, NUP35, NUPL2, NUP37]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[FASLG, ARRB1, TNF, CYR61, CTGF, PYCARD, CTSH, SOX7, DAPK1, F2R, SIRT1, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, GSN, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CDC20, TRIM25, SKP2, CDC34, PLK1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PSMD14, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, BIRC2, AURKB, TBX21, RNF24, PML]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0010906;regulation of glucose metabolic process;7.0;0.6763753087927167;0.6891070196535589;8.753055515138222;59.50955823828417;5.171903441692378;0.00199173135911005;0.615410747783455;[RORA, AKT1, PHLDA2, DGAT2, IGFBP5, IGFBP3, SIRT1, SIK1, FBP1, FOXO1, SORBS1, PPP1CA, FOXA2]
GO:0035508;positive regulation of myosin-light-chain-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1250.9738681086212;9.777073627680469;0.0418689695622076;0.9324289523296623;[PPP1R12A]
GO:0043162;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;9.0;1.0;0.896240625180289;9.628524252492122;157.5507831317809;7.004484905440688;0.005273082924921447;0.7544503089863854;[NEDD4, VPS4B]
GO:0014829;vascular smooth muscle contraction;9.0;0.8653626801206646;0.8289219652406215;9.517298617381897;55.68627484309891;7.138016298065211;0.0018637695046048635;0.7612791106150483;[ACTA2, EDN1, EDNRA, EDNRB, CD38, PIK3C2A, SLC8A1]
GO:0071168;protein localization to chromatin;7.0;0.7369933605727446;0.7194160455435727;8.935377071932177;34.71951895434896;6.832634648514029;0.001162031053863633;0.7003406189322132;[RUVBL2, RAD21, PLK1, ESCO2, EZH2]
GO:0071441;negative regulation of histone H3-K14 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1489.6293825007795;9.777073627680469;0.04985655485289462;0.9481203125901445;[SIRT1]
GO:0032510;endosome to lysosome transport via multivesicular body sorting pathway;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;127.43112785876568;8.390779266560578;0.004265005168863507;0.7800242071602487;[VPS4B]
GO:1990619;histone H3-K9 deacetylation;11.0;1.0;0.9324289523296623;9.628524252492122;359.8035512049472;9.083926447120524;0.012042301056656516;0.8969813732811862;[SIRT1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, NLRC4, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0032071;regulation of endodeoxyribonuclease activity;8.0;0.7436939687323844;0.7468469843661922;9.310070521373587;159.39497753169505;7.697632086000634;0.0053348064518193685;0.7686572628545723;[GZMA, PRKCD, AKT1, SIRT1]
GO:0048339;paraxial mesoderm development;5.0;1.0;0.7902410118609202;9.628524252492122;34.03910770959907;7.697632086000634;0.0011392583018322185;0.6838982747154925;[YAP1, EPB41L5, NUP133]
GO:0006343;establishment of chromatin silencing;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.24116723228514;9.777073627680469;7.10922751455178E-4;0.7902410118609202;[SIRT1]
GO:1900113;negative regulation of histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;912.0848673078575;8.390779266560578;0.03052665968570576;0.8772251544931927;[SIRT1]
GO:0006344;maintenance of chromatin silencing;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.24116723228514;8.390779266560578;7.10922751455178E-4;0.7193458537639684;[SIRT1]
GO:0042595;behavioral response to starvation;6.0;1.0;0.8231203125901445;9.628524252492122;23.524030502816238;9.083926447120524;7.873281306762962E-4;0.7876727335416686;[SIRT1]
GO:0045900;negative regulation of translational elongation;9.0;0.8259837884571596;0.8092325194088689;9.52031066785189;1334.6807050748262;8.390779266560578;0.04467056206420413;0.8253454670833372;[SRP9]
GO:0006622;protein targeting to lysosome;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;250.3799473132135;6.781341354126479;0.008379991509250163;0.7792270645443136;[SCARB2, CLU, ZFYVE16, HGS, NEDD4, LAMP2]
GO:0045348;positive regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[IL10, CIITA, AZU1, SIRT1]
GO:0006620;posttranslational protein targeting to endoplasmic reticulum membrane;11.0;1.0;0.9324289523296623;9.628524252492122;336.65241395888097;7.57984905034425;0.011267453327701498;0.8200627852632958;[SEC63]
GO:0022027;interkinetic nuclear migration;6.0;1.0;0.8231203125901445;9.628524252492122;68.32040627354414;7.9853141584524145;0.0022866225136017795;0.7314896500084853;[HHEX, CEP120]
GO:0006346;methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1936.9706715625437;7.212124270218933;0.06482866521676948;0.8169486831672182;[SIRT1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, PARP9, IL1B, SP100, SATB2, RXRA, CDX2, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0006616;SRP-dependent cotranslational protein targeting to membrane, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;169.63248762716802;7.57984905034425;0.005677446701553932;0.8028748447945538;[SRP9]
GO:2000619;negative regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1675.3938874144621;8.67846133901236;0.056073925655155225;0.9063718812344532;[SIRT1]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0006614;SRP-dependent cotranslational protein targeting to membrane;12.0;1.0;0.9481203125901445;9.628524252492122;336.65241395888097;5.288437257948329;0.011267453327701498;0.718571239899105;[SEC63, SRP9]
GO:0031937;positive regulation of chromatin silencing;11.0;0.8259837884571596;0.845420846558242;9.478992518521158;424.62505234881525;7.697632086000634;0.014211818364378214;0.8260862151842345;[SIRT1]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[YAP1, CDKN1A, BLM, FIGNL1, ECT2, EGR1, TGFB1, H2AFX, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4, BCL2L1]
GO:0033158;regulation of protein import into nucleus, translocation;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;190.5797269763205;6.943860283624253;0.006378531951278581;0.7513499630073597;[MED1, CDKN1A, IFNG, LRRK2, CDK1, SIRT1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:1904562;phosphatidylinositol 5-phosphate metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;149.40095957869912;9.083926447120524;0.005000315664964811;0.839552420951524;[PIKFYVE]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, ETS1, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, CYBB, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, RIPK2, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, AIF1, GNAI1, CST3, CCL7, CTNNA1, FYN, KLF4, MAPK13, FABP1, RAD51, CD69]
GO:0090400;stress-induced premature senescence;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;55.82928668984125;7.697632086000634;0.0018685559824130236;0.6838982747154925;[CDKN1A, MAPK14, SIRT1]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, PPP1R12A, DUSP3, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, RORA, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, PKIG, HOXC10, CHAF1B, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, E2F1, E2F2, E2F5, E2F7, POU2AF1, SMARCAL1, IKZF1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, TCF4, MXD1, FBN1, TNFAIP3, LYL1, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, TBX21, RRM2, CD4, PHB2, PRKCH, PRKCQ, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, SNAI2, CDKN1A, BTG2, ZNF367, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, PURA, GRHL2, CD40LG, HOXA11, HOXA10, LMO2, FANCD2, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, PRRX1, CCNH, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, CREBZF, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[CSF3, AKT1, MEF2C, F2R, MSH2, ADAM8, NAIP, C5AR1, SLC30A10, CORO1A, HMOX1, FZD1, JUN, WFS1, NR4A2, NR4A3, BCL2, BCL2L1, NRP1, BTG2, LRRK2, ARRB1, ARRB2, CHL1, CD34, IL10, SIRT1, CEBPB, LRP1, GPNMB, NTF3, CCL2, FYN, SNCA, GABRA5, SOD2, POU4F1]
GO:0045876;positive regulation of sister chromatid cohesion;9.0;0.7436939687323844;0.7680876095464813;9.292052015870908;259.00348872071737;7.474488534686424;0.008668613679475917;0.7784863164434164;[FEN1, RAD21]
GO:0000012;single strand break repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;7.474488534686424;0.006126539929698291;0.7572456912631272;[SIRT1]
GO:0030953;astral microtubule organization;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.68103242922432;7.8311634786251565;0.0032692962481843716;0.7514054297404357;[CEP120]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[ZFAND6, EHHADH, SLC27A2, HSD17B4]
GO:0002821;positive regulation of adaptive immune response;6.0;0.6162540371078848;0.6312473311440869;8.312847458586184;108.8065326900253;5.202362649177086;0.0036416567296131998;0.5891693804036648;[CD40, TFRC, CD80, TNF, TNFSF13B, PYCARD, IL6R, CCR2, ANXA1, FCER1G, RSAD2, RIPK2, SLC11A1, IL18, SIRT1, MSH6, FCER2, MSH2, IL23A, IL1B, BTK, LTA, XCL1, PRKCQ, CD274, CD1E, GATA3, CD1D, CD1C, CD1B, PRKCZ, CD1A, UNG, HSPD1, C3, HLX, TBX21, NLRP3, CCL19, IL12RB1, TGFB1, FZD5, TNFSF13, MLH1, CD4, IL6, CD28]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[VPS4B, CEP120, FIGNL1, TUBG1]
GO:0036258;multivesicular body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;6.375876246018314;0.0020992917763011008;0.6769819729871445;[VPS4B, HGS]
